Atlas Venture Life Science Advisors as of Sept. 30, 2023
Portfolio Holdings for Atlas Venture Life Science Advisors
Atlas Venture Life Science Advisors holds 15 positions in its portfolio as reported in the September 2023 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Disc Medicine Common Stock (IRON) | 20.0 | $129M | 2.7M | 46.98 | |
| Day One Biopharmaceuticals Common Stock (DAWN) | 14.5 | $93M | 7.6M | 12.27 | |
| Dyne Therapeutics Common Stock (DYN) | 13.7 | $89M | 9.9M | 8.96 | |
| Kymera Therapeutics Common Stock (KYMR) | 12.6 | $81M | 5.9M | 13.90 | |
| Third Harmonic Bio Common Stock (THRD) | 10.8 | $70M | 11M | 6.39 | |
| Replimune Group Common Stock (REPL) | 5.6 | $36M | 2.1M | 17.11 | |
| Vigil Neuroscience Common Stock (VIGL) | 4.9 | $32M | 5.8M | 5.39 | |
| Generation Bio Common Stock (GBIO) | 4.9 | $31M | 8.3M | 3.79 | |
| Aerovate Therapeutics Common Stock (AVTE) | 4.3 | $28M | 2.0M | 13.57 | |
| Ikena Oncology Common Stock (IKNA) | 3.4 | $22M | 5.0M | 4.33 | |
| Akero Therapeutics Common Stock (AKRO) | 2.8 | $18M | 359k | 50.58 | |
| AvroBio Common Stock (AVRO) | 1.1 | $7.0M | 4.5M | 1.54 | |
| Xilio Therapeutics Common Stock (XLO) | 0.9 | $5.8M | 2.8M | 2.11 | |
| Dianthus Therapeutics Common Stock (DNTH) | 0.5 | $3.2M | 237k | 13.67 | |
| Spero Therapeutics Common Stock (SPRO) | 0.2 | $1.2M | 1.0M | 1.21 |
